STAMPEDEing metastatic prostate cancer: CHAARTing the LATITUDEs

STAMPEDEing metastatic prostate cancer: CHAARTing the LATITUDEs

With the emergence of recent landmark trials, the treatment for hormone-sensitive metastatic prostate cancer (hsMPC) is changing from androgen deprivation therapy (ADT) alone to combination therapy. Both, docetaxel chemotherapy and abiraterone in addition to ADT have been extensively studied in well...

Full description

Bibliographic Details
Main Authors: Aditya Prakash Sharma, Ravimohan S Mavuduru, Girdhar Singh Bora, Sudheer K Devana, Shrawan K Singh, Arup K Mandal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Indian Journal of Urology
Online Access:http://www.indianjurol.com/article.asp?issn=0970-1591;year=2018;volume=34;issue=3;spage=180;epage=184;aulast=Sharma

Internet

http://www.indianjurol.com/article.asp?issn=0970-1591;year=2018;volume=34;issue=3;spage=180;epage=184;aulast=Sharma

Similar Items